Minnesota SF 4058: Commissioner of human services authorization to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases

Status: Referred to Health and Human Services (as of 2024-02-22)

State: Minnesota · Session: 2023-2024 · Bill: SF 4058

Subjects: Health and Health Department, Hospitals and Health Care Facilities, Human Services and Human Services Department

Sponsors: Boldon, Champion, Coleman

View Minnesota SF 4058 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.